{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:29:40Z","timestamp":1761845380317,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Primary ovarian high-grade endometrial stromal sarcoma is a very rare disease. Even though it has poor prognosis, the gold standard treatment has not been established owing to its rarity. This report aimed to present therapeutic options for primary ovarian high-grade endometrial stromal sarcoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 49-year-old Asian woman presented with disseminated intravascular coagulation due to ruptured primary high-grade ovarian endometrial stromal sarcoma with multiple intraperitoneal metastases. After the initial surgery, the patient underwent adjuvant chemotherapy with three courses of Adriamycin (75\u00a0mg\/m<jats:sup>2<\/jats:sup>). We performed the secondary debulking operation including total hysterectomy, metastasectomy, omentectomy, peritonectomy, appendectomy, and hyperthermic intraperitoneal chemotherapy (paclitaxel 175\u00a0mg\/m<jats:sup>2<\/jats:sup>). Currently she has been alive for 28\u00a0months under a new chemotherapy regimen.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We suggest cytoreductive surgery with hyperthermic intraperitoneal chemotherapy could be a therapeutic option for primary high-grade ovarian endometrial stromal sarcoma with peritoneal dissemination.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-021-02986-0","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T23:10:21Z","timestamp":1627945821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Primary ovarian high-grade endometrial stromal sarcoma: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Ji Sun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jisun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man-Hoon","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Gy","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3942-405X","authenticated-orcid":false,"given":"Hyun Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,3]]},"reference":[{"key":"2986_CR1","first-page":"20","volume":"5","author":"H Brustmann","year":"2010","unstructured":"Brustmann H, Geiss IM, Hinterholzer S. Undifferentiated endometrial sarcoma of the ovary: a case report with review of recent literature and discussion of lacking specificity of CD10 immunoreactivity. Pathol Res Int. 2010;5:20.","journal-title":"Pathol Res Int"},{"issue":"4","key":"2986_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/00004347-199310000-00002","volume":"12","author":"KL Chang","year":"1993","unstructured":"Chang KL, Crabtree GS, Lim-Tan SK, Kempson RL, Hendrickson MR. Primary extrauterine endometrial stromal neoplasms: a clinicopathologic study of 20 cases and a review of the literature. Int J Gynecol Pathol. 1993;12(4):282\u201396.","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"2986_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.5468\/ogs.2016.59.4.323","volume":"59","author":"JA Back","year":"2016","unstructured":"Back JA, Choi MG, Ju UC, Kang WD, Kim SM. A case of advanced-stage endometrial stromal sarcoma of the ovary arising from endometriosis. Obstetr Gynecol Sci. 2016;59(4):323\u20137.","journal-title":"Obstetr Gynecol Sci"},{"issue":"1","key":"2986_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40661-019-0067-7","volume":"6","author":"B Efared","year":"2019","unstructured":"Efared B, Sidib\u00e9 IS, Erregad F, Hammas N, Chbani L, El Fatemi H. Extra-uterine low grade endometrioid stromal sarcoma arising from ovarian endometriosis: a case report and review of the literature. Gynecol Oncol Res Pract. 2019;6(1):2.","journal-title":"Gynecol Oncol Res Pract"},{"issue":"3","key":"2986_CR5","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.ygyno.2007.01.031","volume":"105","author":"CA Leath III","year":"2007","unstructured":"Leath CA III, Huh WK, Hyde J Jr, Cohn DE, Resnick KE, Taylor NP, et\u00a0al. A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol Oncol. 2007;105(3):630\u20134.","journal-title":"Gynecol Oncol"},{"issue":"38","key":"2986_CR6","doi-asserted-by":"publisher","first-page":"63345","DOI":"10.18632\/oncotarget.18805","volume":"8","author":"W Xie","year":"2017","unstructured":"Xie W, Bi X, Cao D, Yang J, Shen K, You Y. Primary endometrioid stromal sarcomas of the ovary: a clinicopathological study of 14 cases with a review of the literature. Oncotarget. 2017;8(38):63345.","journal-title":"Oncotarget"},{"issue":"2","key":"2986_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1028-4559(09)60066-8","volume":"43","author":"C-C Chia","year":"2004","unstructured":"Chia C-C, Wu M-P, Huang K-F, Su C-C. Primary stromal sarcoma of the ovary: a case report. Taiwan J Obstet Gynecol. 2004;43(2):110\u20132.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"1","key":"2986_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/0971-5851.96960","volume":"33","author":"G Puliyath","year":"2012","unstructured":"Puliyath G, Nair MK. Endometrial stromal sarcoma: a review of the literature. Indian J Med Paediatr Oncol. 2012;33(1):1.","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"11","key":"2986_CR9","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1097\/PAS.0000000000000083","volume":"37","author":"RP Masand","year":"2013","unstructured":"Masand RP, Euscher ED, Deavers MT, Malpica A. Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases. Am J Surg Pathol. 2013;37(11):1635\u201347.","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2986_CR10","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1002\/1097-0142(19881001)62:7<1355::AID-CNCR2820620719>3.0.CO;2-4","volume":"62","author":"B Patsner","year":"1988","unstructured":"Patsner B, Mann WJ. Use of serum CA-125 in monitoring patients with uterine sarcoma: a preliminary report. Cancer. 1988;62(7):1355\u20138.","journal-title":"Cancer"},{"issue":"6","key":"2986_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/PAP.0000000000000046","volume":"21","author":"CM Conklin","year":"2014","unstructured":"Conklin CM, Longacre TA. Endometrial stromal tumors: the new WHO classification. Adv Anat Pathol. 2014;21(6):383\u201393.","journal-title":"Adv Anat Pathol"},{"issue":"12","key":"2986_CR12","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/S1470-2045(09)70226-8","volume":"10","author":"F Amant","year":"2009","unstructured":"Amant F, Coosemans A, Debiec-Rychter M, Timmerman D, Vergote I. Clinical management of uterine sarcomas. Lancet Oncol. 2009;10(12):1188\u201398.","journal-title":"Lancet Oncol"},{"key":"2986_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/IGC.0b013e3181b33c9a","volume":"19","author":"B Barney","year":"2009","unstructured":"Barney B, Tward JD, Skidmore T, Gaffney DK. Does radiotherapy or lymphadenectomy improve survival in endometrial stromal sarcoma? Int J Gynecol Cancer. 2009;19:7.","journal-title":"Int J Gynecol Cancer."},{"issue":"3","key":"2986_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ajog.2013.11.002","volume":"210","author":"WA Jimenez","year":"2014","unstructured":"Jimenez WA, Sardi A, Nieroda C, Gushchin V. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of recurrent high-grade uterine sarcoma with peritoneal dissemination. Am J Obstetr Gynecol. 2014;210(3):259.","journal-title":"Am J Obstetr Gynecol"},{"issue":"11","key":"2986_CR15","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.ejso.2017.08.011","volume":"43","author":"A Sardi","year":"2017","unstructured":"Sardi A, Sipok A, Baratti D, Deraco M, Sugarbaker P, Salti G, et\u00a0al. Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 2017;43(11):2170\u20137.","journal-title":"Eur J Surg Oncol"},{"key":"2986_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijscr.2019.09.009","volume":"64","author":"PH Sugarbaker","year":"2019","unstructured":"Sugarbaker PH. Long-term survival is possible using cytoreductive surgery plus HIPEC for sarcomatosis\u2014case report of 2 patients. Int J Surg Case Rep. 2019;64:10\u20134.","journal-title":"Int J Surg Case Rep"},{"issue":"36","key":"2986_CR17","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, et\u00a0al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27(36):6237\u201342.","journal-title":"J Clin Oncol"},{"issue":"7","key":"2986_CR18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ejso.2013.02.018","volume":"39","author":"N Bakrin","year":"2013","unstructured":"Bakrin N, Gilly F, Baratti D, Bereder J, Quenet F, Lorimier G, et\u00a0al. Primary peritoneal serous carcinoma treated by cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. A multi-institutional study of 36 patients. EJSO. 2013;39(7):742\u20137.","journal-title":"EJSO."}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02986-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-02986-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02986-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T23:14:49Z","timestamp":1627946089000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-02986-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2986"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-02986-0","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2021,8,3]]},"assertion":[{"value":"26 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"387"}}